Drug recall · August 6, 2014
Cardura XL recall
Why: Failed Impurities/Degradation Specifications: Product from this lot may not meet specifications for a product degradant.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Cardura XL (doxazosin mesylate extended release tablets, 4 mg, 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., New York, NY 10017, NDC 0049-2710-30
- Lots / codes
Lot # V130822; Exp 01/15
- Quantity
- 22,461 bottles
- Company
- Pfizer Inc., New York, NY
- Distribution
- Nationwide (Continental USA and Puerto Rico). A portion of the bulk lot was supplied to Pfizer Germany for packaging into blisters for non- USA market. One of these lots in Germany was placed in stability having acceptable results, therefore are not part of the recall scope. Only the product distributed within US/PR market (bottles) is in the scope of this recall.
- Initiated
- June 19, 2014 · Voluntary: Firm initiated
- Classified
- July 28, 2014
- Reported
- August 6, 2014
- Ended
- June 3, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Doxazosin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.